google.com, pub-2441454515104767, DIRECT, f08c47fec0942fa0

Pine Labs IPO Opens Today: Price Band, GMP, Subscription Status, and Should You Apply?

Axpertv media google source

Pine Labs IPO Kicks Off: All Eyes on ₹3,900 Crore Fintech Giant

The Pine Labs IPO opened for subscription today, November 7, 2025, marking one of the most anticipated listings in India’s fintech space. The digital payments and merchant commerce platform plans to raise ₹3,899.91 crore from the public issue, which will close on November 11.

WhatsApp Group Join Now
Telegram Group Join Now
Instagram Group Join Now

The company has set the IPO price band at ₹210–₹221 per share, with a lot size of 67 shares, requiring a minimum investment of ₹14,807 from retail investors.

At the upper end of the price band, the issue includes a fresh equity issue worth ₹2,080 crore and an offer-for-sale (OFS) of ₹1,819.91 crore by existing shareholders.

IPO Timeline and Listing Details

Investors can subscribe to the IPO between November 7 and November 11, with the allotment expected on November 12. Shares are likely to be listed on the BSE and NSE by November 14.

Axis Capital Ltd is the book-running lead manager, while Kfin Technologies Ltd is handling the registrar responsibilities.

Read More :- Groww IPO Day 3: Live Subscription Status, Allotment Date, and How to Check Your Shares

Pine Labs IPO GMP Today

The Pine Labs IPO is off to a steady start in the grey market. According to market watchers, the grey market premium (GMP) stands at ₹12 per share, implying that Pine Labs shares are trading at ₹233 in the unlisted market — around 5.4% higher than the issue price.

This modest GMP signals cautious optimism among investors ahead of Day 1 subscription data.

Pine Labs IPO Subscription Status (Day 1)

Bidding for the Pine Labs IPO began at 10:00 AM today. The subscription data will be updated later in the day, giving a clearer picture of retail and institutional demand.

About Pine Labs: Fintech Powerhouse with Global Reach

Pine Labs isn’t just another payments player. The company has built a robust merchant network of 9.8 lakh merchants, working with 716 consumer brands and 177 financial institutions across India, Malaysia, Singapore, UAE, Australia, the USA, and Africa.

The firm counts major clients like HDFC Bank, Croma, and LG Electronics, reflecting its deep market credibility.

Between FY23 and FY25, Pine Labs reported impressive growth — revenue CAGR at 19.3% and EBITDA CAGR at a whopping 538.6%. Part of the IPO proceeds (₹532 crore) will go towards debt repayment, strengthening its balance sheet.

Analysts’ Take: Apply or Wait?

Market experts are divided on the IPO’s valuation and long-term potential.

SBI Securities recommends subscribing for the long term, citing Pine Labs’ strong business fundamentals and turnaround in profitability. “The company is well-positioned to capture India’s massive ₹276 trillion digital payments opportunity by FY29,” the brokerage noted.

On the other hand, Swastika Investmart advised caution, calling the issue “aggressively valued” with limited short-term upside.

In simple terms — if you’re a long-term investor, Pine Labs might be worth considering. But for short-term listing gains, the premium may not be very exciting.

Read More :- Groww IPO Opens For Subscription: Here’s Everything You Need To Know About Day 1 Status, Price Band & GMP

Final Verdict

Pine Labs brings a credible brand, strong financial recovery, and big market ambitions — but at a premium price tag. For investors betting on the future of India’s fintech story, this IPO could be a calculated risk worth taking for the long haul.

Axpert Media Markets Desk
Axpert Media Markets Deskhttps://axpertmedia.in/
Axpert Media Markets Desk delivers fast, factual, and insightful coverage of India’s stock markets, business trends, and financial updates. From Sensex and Nifty movements to RBI policy and IPO news, the team focuses on clarity, accuracy, and trusted market analysis for readers and investors alike.

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here